Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. 1999

B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
Quebec Heart Institute, Laval Hospital and Faculties of Pharmacy and Medicine, Laval University, Sainte-Foy, Quebec, Canada.

Proarrhythmia has been observed with the antipsychotic agent thioridazine (THIO). The mechanisms underlying these effects are unknown. The objectives of this study were 1) to characterize the effects of THIO on cardiac repolarization and 2) to determine whether lengthening of the Q-T interval could be explained by blocking major K+-repolarizing currents. Isolated, buffer-perfused guinea pig hearts (n = 32) were stimulated at various pacing cycle lengths (150-250 ms) and exposed to THIO at concentrations ranging from 300 nM to 3 microM. THIO increased monophasic action potential duration at 90% repolarization (MAPD90) in a concentration-dependent manner from 14.9 +/- 1.8 at 300 nM to 37.1 +/- 3.2 ms at 3 microM. Increase in MAPD90 was also reverse frequency-dependent; THIO (300 nM) increased MAPD90 by 14.9 +/- 1.8 ms at a pacing cycle length of 250 ms, but by only 7.7 +/- 1.2 ms at a pacing cycle length of 150 ms. Patch-clamp experiments demonstrated that THIO decreases the time-dependent outward K+ current elicited by short depolarizations (250 ms; IK250) in a concentration-dependent manner. Estimated IC50 for IK250, which mostly underlies IKr, was 1.25 microM. Time-dependent outward K+ current elicited in tsA201 cells expressing high levels of HERG protein was also decreased approximately 50% by 1.25 microM THIO. On the other hand, THIO was less potent (IC50 of 14 microM) to decrease time-dependent K+ current elicited by long pulses (5000 ms; IK5000). Under the latter conditions, IK5000 corresponds mainly to IKs. Thus, these results demonstrate block of K+ currents and lengthening of cardiac repolarization by THIO in a concentration-dependent manner. This may provide an explanation of Q-T prolongation observed in some patients treated with THIO.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013881 Thioridazine A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA. Aldazine,Apo-Thioridazine,Meleril,Mellaril,Melleretten,Melleril,Melleryl,Melzine,Rideril,Sonapax,Thioridazine HCL,Thioridazine Hydrochloride,Thioridazine-Neurazpharm,Thiozine,Apo Thioridazine,ApoThioridazine,Thioridazine Neurazpharm,ThioridazineNeurazpharm

Related Publications

B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
June 1995, Circulation,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
July 2001, Journal of cardiovascular pharmacology and therapeutics,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
June 2003, Journal of cardiovascular pharmacology,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
September 2007, Journal of psychopharmacology (Oxford, England),
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
December 1999, Journal of cardiovascular electrophysiology,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
July 2000, Circulation,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
June 2001, Circulation,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
December 1998, Cardiovascular research,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
July 1994, Pflugers Archiv : European journal of physiology,
B Drolet, and F Vincent, and J Rail, and M Chahine, and D Deschênes, and S Nadeau, and M Khalifa, and B A Hamelin, and J Turgeon
February 2002, Pharmacological research,
Copied contents to your clipboard!